F. Manzarbeitia-rekin lankidetzan egindako argitalpenak (2)

2008

  1. Receptor activator of nuclear factor-κB ligand (RANKL) as a novel prognostic marker in prostate carcinoma

    Histology and Histopathology, Vol. 23, Núm. 6, pp. 709-715

2007

  1. Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: Relative chanqes or parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand

    Journal of Clinical Pathology, Vol. 60, Núm. 3, pp. 290-294